Liver disease in cystic fibrosis

Because of improved survival in the past two decades, liver disease has assumed greater importance in patients with cystic fibrosis. Clinical detection has been difficult thus far. In recent years, advances in our understanding of pathogenesis as well as increasing experience in therapeutic modaliti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tombazzi,Claudio R, Riely,Caroline A
Lenguaje:	English
Publicado:	Sociedad Médica de Santiago 2001
Materias:	Cholestasis, intrahepatic Cystic Fibrosis Cystic Fibrosis transmembrane regulator Liver diseases Ursodeoxycholic acid
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000900015
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872001000900015
record_format	dspace
spelling	oai:scielo:S0034-988720010009000152005-11-24Liver disease in cystic fibrosisTombazzi,Claudio RRiely,Caroline A Cholestasis, intrahepatic Cystic Fibrosis Cystic Fibrosis transmembrane regulator Liver diseases Ursodeoxycholic acid Because of improved survival in the past two decades, liver disease has assumed greater importance in patients with cystic fibrosis. Clinical detection has been difficult thus far. In recent years, advances in our understanding of pathogenesis as well as increasing experience in therapeutic modalities have been accomplished. For these reasons, it is relevant to review this topic (Rev Med Chile 2001; 129: 1071-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.9 20012001-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000900015en10.4067/S0034-98872001000900015
institution	Scielo Chile
collection	Scielo Chile
language	English
topic	Cholestasis, intrahepatic Cystic Fibrosis Cystic Fibrosis transmembrane regulator Liver diseases Ursodeoxycholic acid
spellingShingle	Cholestasis, intrahepatic Cystic Fibrosis Cystic Fibrosis transmembrane regulator Liver diseases Ursodeoxycholic acid Tombazzi,Claudio R Riely,Caroline A Liver disease in cystic fibrosis
description	Because of improved survival in the past two decades, liver disease has assumed greater importance in patients with cystic fibrosis. Clinical detection has been difficult thus far. In recent years, advances in our understanding of pathogenesis as well as increasing experience in therapeutic modalities have been accomplished. For these reasons, it is relevant to review this topic (Rev Med Chile 2001; 129: 1071-8)
author	Tombazzi,Claudio R Riely,Caroline A
author_facet	Tombazzi,Claudio R Riely,Caroline A
author_sort	Tombazzi,Claudio R
title	Liver disease in cystic fibrosis
title_short	Liver disease in cystic fibrosis
title_full	Liver disease in cystic fibrosis
title_fullStr	Liver disease in cystic fibrosis
title_full_unstemmed	Liver disease in cystic fibrosis
title_sort	liver disease in cystic fibrosis
publisher	Sociedad Médica de Santiago
publishDate	2001
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000900015
work_keys_str_mv	AT tombazziclaudior liverdiseaseincysticfibrosis AT rielycarolinea liverdiseaseincysticfibrosis
_version_	1718435993666715648

Liver disease in cystic fibrosis

Ejemplares similares